Shu Mei Kato
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Personalized Cancer Therapy to Determine Response and Toxicity (NCT02478931) | Shu Mei Kato | 2013-09-05 |
Track Shu Mei Kato automatically
Every clearance here is in the API, with alerts when new ones post.